Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acuren Corp Ltd | E. Martin Franklin | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 19,545,847 | 0 | - | 0 | Common Stock | |
| APi Grp Corp | E. Martin Franklin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 8,084,991 | 8,100,243 | - | 0 | Common Stock | |
| APi Grp Corp | E. Franklin Martin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 5,771,316 | 24,740,106 | - | 0 | Common Stock | |
| APi Grp Corp | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 5,771,316 | 2,270,987 | - | 0 | Common Stock | |
| Acuren Corp Ltd | Franklin E. Martin | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 5,410,813 | 5,410,813 | - | 0 | Common Stock | |
| Mistras Grp Inc | Aspasia Felice Vahaviolos | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 5,251,358 | 854,292 (2%) | 18% | 0 | Common Stock | |
| Acuren Corp Ltd | E. Martin Franklin | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 4,851,977 | 4,851,977 | - | 0 | Common Stock | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | 31 Dec 2025 | 3,155,170 | 3,155,170 | - | - | Stock Options (right to buy) | ||
| Nike | Travis A. Knight | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 3,000,000 | 4,694,859 (0%) | 0% | 0 | Class B Common Stock | |
| Nike | Travis A. Knight | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 3,000,000 | 33,940 (0%) | 0% | 0 | Class B Common Stock | |
| Nike | Travis A. Knight | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 3,000,000 | 3,033,940 (0%) | 0% | 0 | Class B Common Stock | |
| Zeo Energy Corp (Class A) | Brandon Bridgewater | CSO | 31 Dec 2025 | 3,000,000 | 3,000,000 | - | 0 | Class A Common Stock | ||
| Zeo Energy Corp (Class A) | Brandon Bridgewater | CSO | 31 Dec 2025 | 3,000,000 | 2,515,664 | - | 0 | Class V Common Stock | ||
| APi Grp Corp | Martin Franklin E. | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,168,331 | 2,711,692 | - | 0 | Common Stock | |
| APi Grp Corp | Martin Franklin E. | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,168,331 | 102,656 | - | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 2,049,517 (2%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 13,209 (0%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,000,248 | 2,000,248 (2%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,000,248 | 13,209 (0%) | 2% | 0 | Common Stock | |
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 2,000,000 | 2,500,000 | - | 0 | Class A Common Stock | ||
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 2,000,000 | 3,015,664 | - | 0 | Class V Common Stock | ||
| Acuren Corp Ltd | Martin Franklin E. | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,952,745 | 1,952,745 | - | 0 | Common Stock | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | 31 Dec 2025 | 1,851,852 | 12,273,280 (68%) | 10% | 1.4 | 2,537,037 | Common Stock | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | 31 Dec 2025 | 1,851,852 | 0 | - | - | 3.5-Year Common Stock Warrant | ||
| Acuren Corp Ltd | Lillie E. James | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,806,291 | 0 | - | 0 | Common Stock | |
| Acuren Corp Ltd | Lillie E. James | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,806,291 | 1,816,291 | - | 0 | Common Stock | |
| Lesaka Tech Inc | Ali Mazanderani Haeri | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 31 Dec 2025 | 1,800,000 | 2,325,115 (4%) | 3% | 5 | 9,000,000 | Common Stock |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,787,841 | 1,787,841 (0%) | 0% | 0 | Class A Common Stock | |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,787,841 | 1,787,841 (0%) | 0% | 0 | Class A Common Stock | |
| Opendoor Tech Inc | Christina Schwartz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,695,000 | 3,918,462 | - | 0 | Common Stock | |
| Opendoor Tech Inc | Christina Schwartz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,695,000 | 2,223,462 | - | 0 | Common Stock | |
| Nike | Travis A. Knight | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,694,859 | 1,694,859 (0%) | 0% | 0 | Class B Common Stock | |
| Nextdoor Holdings Inc (Class A) | Amresh Indrajit Ponnambalam | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,651,982 | 1,651,982 | - | - | Restricted Stock Units (RSU) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,500,258 | 1,500,258 | - | - | Stock Option (right to buy) | |
| Sow Good Inc | David Elliot Lazar | Director, Chief Executive Officer | 31 Dec 2025 | 1,500,000 | 1,500,000 | - | - | Series AA Preferred Stock | ||
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,350,000 | 8,066,771 | - | 0.0 | 1,350 | Common Stock, par value $.001 |
| BRC Inc (Class A) | Evan Hafer | Director, Founder, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,146,727 | 1,146,727 | - | - | Stock Option (Right to Buy) | |
| Acuren Corp Ltd | Robert A E Franklin | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,117,394 | 1,117,394 | - | 0 | Common Stock | |
| Acuren Corp Ltd | Franklin A E Robert | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,117,394 | 0 | - | 0 | Common Stock | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 1,015,687 | 1,421,177 | - | - | Class B Common Stock | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 981,162 | 2,943,485 | - | - | Performance-Based Restricted Stock Units | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 981,162 | 1,197,862 | - | - | Common stock, $0.001 par value per share | |
| Choice Hotels Intl Inc | Bainum Bruce | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 800,000 | 1,928,415 (3%) | 1% | 0 | Common Stock | |
| Choice Hotels Intl Inc | Bainum Bruce | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 800,000 | 1,128,415 (2%) | 1% | 0 | Common Stock | |
| Choice Hotels Intl Inc | Bainum Bruce | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 800,000 | 1,600,000 (2%) | 1% | 0 | Common Stock | |
| Choice Hotels Intl Inc | Bainum Bruce | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 800,000 | 800,000 (1%) | 1% | 0 | Common Stock | |
| Permian Resources Corp (Class A) | Guy M. Oliphint | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 711,291 | 918,424 (0%) | 0% | 0 | Class A Common Stock | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 668,789 | 668,789 | - | - | Stock Option (right to buy) | |
| Acuren Corp Ltd | Franklin Martin E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 668,347 | 19,545,847 | - | 0 | Common Stock | |
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | 31 Dec 2025 | 616,024 | 0 | - | - | Class B Common Stock | ||
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | 31 Dec 2025 | 616,024 | 633,754 | - | 0 | Class A Common Stock | ||
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | 31 Dec 2025 | 616,024 | 1,109,712 | - | 0 | Class A Common Stock | ||
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | 31 Dec 2025 | 616,024 | 17,730 | - | 0 | Class A Common Stock | ||
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 31 Dec 2025 | 613,595 | 3,592,666 | - | 2.1 | 1,294,685 | Common Stock |
| QXO Inc | Bradley S. Jacobs | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 574,901 | 3,257,775 | - | - | Restricted Stock Units | |
| QXO Inc | Bradley S. Jacobs | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 574,901 | 574,901 (12%) | 12% | 0 | Common Stock, $0.00001 par value | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 564,270 | 5,386,610 | - | - | Restricted Stock Units | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2025 | 535,422 | 662,440 | - | - | Common stock, $0.001 par value per share | |
| Big Sky Industrial Inc | Joshua L. Batchelor | Director, Ten Percent Owner, Member of 10% owner group | 31 Dec 2025 | 534,020 | 5,089,101 (363%) | 38% | 2.5 | 1,323,195 | Common Stock | |
| Newmark Grp Inc (Class A) | Barry M. Gosin | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 531,022 | 885,098 | - | - | Newmark Holdings Exchangeable Limited Partnership Interests | |
| Mistras Grp Inc | Aspasia Felice Vahaviolos | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 528,672 | 1,382,964 (4%) | 1% | 0 | Common Stock | |
| APi Grp Corp | Martin E. Franklin | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 499,680 | 18,469,110 | - | 0 | Common Stock | |
| Cosmos Health Inc | Georgios Terzis | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 490,000 | 1,217,263 | - | 0.0 | 490 | Common Stock, par value $.001 |
| Tutor Perini Corp | Smalley Gary G. | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 477,454 | 558,933 (1%) | 0% | - | Common Stock | |
| Tutor Perini Corp | Gary Smalley G. | Director, CEO and President | Sale or transfer of securities back to the company at price $ 67.02 per share. | 31 Dec 2025 | 477,454 | 81,479 (0%) | 0% | 67.0 | 31,998,967 | Common Stock |
| Tutor Perini Corp | Gary Smalley G. | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 477,454 | 0 | - | - | Cash-Settled Performance Stock Units | |
| Ondas Holdings Inc | Eric A. Brock | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 31 Dec 2025 | 475,000 | 1,461,255 | - | 9.7 | 4,611,348 | Common Stock |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 451,885 | 451,885 | - | - | Stock Option (right to buy) | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 451,417 | 7,674,079 | - | - | Restricted Stock Units | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 451,416 | 1,764,040 | - | - | Class B Common Stock | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 451,416 | 7,222,663 | - | - | Restricted Stock Units | |
| SmartRent Inc (Class A) | Frank D. Martell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 450,000 | 450,000 | - | - | Class A Common Stock | |
| SmartRent Inc (Class A) | Frank D. Martell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 450,000 | 900,000 | - | - | Restricted Stock Units | |
| United Fire Grp Inc | Scott Mcintyre | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 449,675 | 0 (0%) | 1% | 0 | UFCS Common Stock | |
| Century Aluminum Co. | Jesse E. Gary | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 439,090 | 805,237 (0%) | 0% | 0 | Common Stock | |
| BeiGene Ltd (ADR) | Lai Wang | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 427,895 | 1,451,424 (0%) | 0% | 0 | Ordinary Shares | |
| Permian Resources Corp (Class A) | John Charles Bell | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 406,734 | 553,090 (0%) | 0% | 0 | Class A Common Stock | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 406,734 | 537,326 (0%) | 0% | 0 | Class A Common Stock | |
| Choice Hotels Intl Inc | Bainum Roberta | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 400,000 | 400,000 (0%) | 0% | 0 | Common Stock | |
| Choice Hotels Intl Inc | Bainum Roberta | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 400,000 | 2,070,433 (3%) | 0% | 0 | Common Stock | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 31 Dec 2025 | 379,000 | 4,206,259 | - | 0.8 | 318,360 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 379,000 | 379,000 | - | - | Stock Options (right to buy) | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 346,061 | 1,417,979 | - | - | Class B Common Stock | ||
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 31 Dec 2025 | 346,061 | 0 | - | 16.9 | 5,851,511 | Class A Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 346,061 | 346,061 | - | - | Class A Common Stock | ||
| Gogo Inc | Oakleigh Thorne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 336,927 | 1,291,025 (1%) | 0% | - | Common Stock | |
| Gogo Inc | Oakleigh Thorne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 336,927 | 0 | - | - | Restricted Stock Units | |
| Conduent Inc | Clifford Skelton | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 31 Dec 2025 | 333,676 | 4,049,876 (1%) | 0% | 1.9 | 640,658 | Common Stock |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 327,000 | 3,246,238 (18%) | 1% | 0 | Common Stock | |
| Lightwave Logic Inc | James S. Marcelli | Director, CFO, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 307,113 | 946,051 | - | 0 | Common Stock | |
| Newmark Grp Inc (Class A) | Barry M. Gosin | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 300,000 | 3,899,995 (2%) | 0% | - | Class A Common Stock, par value $0.01 per share | |
| WillScot Mobile Mini Holdings Corp | Bradley L. Soultz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 300,000 | 0 | - | - | Performance Stock Units | |
| WillScot Mobile Mini Holdings Corp | Bradley L. Soultz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 300,000 | 431,599 (0%) | 0% | - | Common Stock | |
| QXO Inc | Bradley S. Jacobs | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. | 31 Dec 2025 | 266,467 | 308,434 (6%) | 5% | 21.0 | 5,606,466 | Common Stock, $0.00001 par value |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 263,158 | 604,876 (1%) | 0% | - | Class A Common Stock | |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 263,158 | 0 | - | - | Restricted Stock Units | |
| Cedar Fair L.P. | Selim Antoine Bassoul | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 261,000 | 648,178 (1%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Redwire Corp | Peter Cannito | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 255,000 | 790,478 | - | 0 | Common Stock, par value $0.0001 per share | |
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 250,000 | 3,015,664 | - | 0 | Class V Common Stock | ||
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 250,000 | 2,500,000 | - | 0 | Class A Common Stock | ||
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 250,000 | 3,015,664 | - | 0 | Class V Common Stock | ||
| Zeo Energy Corp (Class A) | Kalen Larsen | COO | 31 Dec 2025 | 250,000 | 2,500,000 | - | 0 | Class A Common Stock | ||
| Torrid Holdings Inc | Ashlee R. Wheeler | See remarks. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 246,479 | 246,479 | - | - | Option to purchase shares | |
| First Interstate BancSystem Inc | Jeremy P. Scott | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 236,808 | 236,808 (0%) | 0% | 0 | Common Stock | |
| First Interstate BancSystem Inc | Geoffrey D. Scott | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 236,808 | 236,808 (0%) | 0% | 0 | Common Stock | |
| Lightwave Logic Inc | Thomas E. Zelibor | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 235,453 | 457,454 | - | 0 | Common Stock | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 31 Dec 2025 | 234,595 | 3,827,259 | - | 1.2 | 272,130 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 234,595 | 234,595 | - | - | Stock Options (right to buy) | |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 232,640 | 2,919,238 (16%) | 1% | 0 | Common Stock | |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 229,657 | 697,143 (1%) | 0% | 0 | common stock | |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 229,657 | 926,800 (1%) | 0% | 0 | common stock | |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 229,657 | 229,657 (0%) | 0% | 0 | common stock | |
| Strata Critical Medical Inc (Class A) | Scott. M Wunsch | CEO, Trinity Air Medical | 31 Dec 2025 | 228,690 | 522,085 | - | 0 | Class A common stock, $0.0001 par value per share | ||
| Interactive Brokers Grp Inc (Class A) | Milan Galik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 224,650 | 3,469,650 (4%) | 0% | 0 | Class A common stock | |
| First Guaranty Bancshares Inc | Smith R. Edgar | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 31 Dec 2025 | 208,996 | 537,266 (5%) | 2% | 5.4 | 1,128,578 | COMMON STOCK |
| Vivakor Inc | Albert Johnson | Director | 31 Dec 2025 | 206,890 | 358,837 | - | 0.5 | 98,066 | Common Stock | |
| Century Aluminum Co. | Jesse E. Gary | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.18 per share. | 31 Dec 2025 | 203,131 | 602,106 (0%) | 0% | 39.2 | 7,958,673 | Common Stock |
| Surgepays Inc | Anthony Evers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 200,000 | 414,924 | - | 0 | Shares of Common Stock | |
| Diversified Energy Co PLC | Bradley Grafton Gray | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Diversified Energy Co PLC | Benjamin Sullivan | Sr EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Choice Hotels Intl Inc | Barbara Bainum | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 200,000 | 2,092,935 (3%) | 0% | 0 | Common Stock | |
| Choice Hotels Intl Inc | Barbara Bainum | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 200,000 | 200,000 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Lawrence Bruno | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 180,722 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Lawrence Bruno | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 180,722 | 370,119 (0%) | 0% | 0 | Common Stock | |
| Torrid Holdings Inc | Chinwe Abaelu | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 176,057 | 176,057 | - | - | Option to purchase shares | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 17.33 per share. | 31 Dec 2025 | 175,707 | 0 | - | 17.3 | 3,045,371 | Class A Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 175,707 | 175,707 | - | - | Class A Common Stock | ||
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 175,707 | 1,242,272 | - | - | Class B Common Stock | ||
| GameSquare Holdings Inc | Louis Schwartz | Director, Former President and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 174,324 | 440,540 | - | - | Common Stock | |
| GameSquare Holdings Inc | Louis Schwartz | Director, Former President and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 174,324 | 0 | - | - | Restricted Stock Units | |
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 164,295 | 803,782 | - | 30.9 | 5,068,501 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Adam Taylor Sullivan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 159,308 | 4,523,244 | - | 0 | Common Stock | |
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 158,798 | 267,184 | - | 30.8 | 4,898,918 | Common Stock |
| QXO Inc | Sean Smith | SEE REMARKS | 31 Dec 2025 | 156,044 | 183,397 (4%) | 3% | 0 | Common Stock, $0.00001 par value | ||
| QXO Inc | Sean Smith | SEE REMARKS | 31 Dec 2025 | 156,044 | 884,254 | - | - | Restricted Stock Units | ||
| Evercore Inc (Class A) | Timothy LaLonde Gilbert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 150,000 | 150,000 | - | - | Class K Units of Evercore LP | |
| Duos Tech Grp Inc | Leah F. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 150,000 | 150,000 (4%) | 4% | - | Common Stock, $0.001 par value | |
| Fold Holdings Inc (Class A) | Jonathan Kirkwood | Director, Ten Percent Owner | 31 Dec 2025 | 148,000 | 148,000 | - | - | 7.0% Convertible Note | ||
| Fold Holdings Inc (Class A) | Jonathan Kirkwood | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 144,311 | 256,811 | - | 0 | Common Stock | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 141,726 | 0 | - | - | Warrants | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 141,726 | 141,726 | - | - | Common stock, $0.001 par value per share | |
| IZEA Worldwide Inc | Patrick J. Venetucci | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 141,616 | 348,047 (1%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | Former CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 140,667 | 192,028 (0%) | 0% | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Todd M. Duchene | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 31 Dec 2025 | 139,873 | 1,938,007 | - | 15.1 | 2,109,285 | Common Stock |
| Torrid Holdings Inc | Ashlee R. Wheeler | See remarks. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 137,796 | 245,239 | - | 0 | Common Stock | |
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 134,706 | 152,667 | - | 30.8 | 4,155,680 | Common Stock |
| F&G Annuities & Life Inc | Raymond R. Quirk | Director | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 132,479 | 298,610 | - | 30.8 | 4,086,977 | Common Stock |
| Redwire Corp | Peter Cannito | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 127,500 | 0 | - | - | Performance-Based Restricted Stock Units | |
| QXO Inc | Ihsan Essaid | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 127,125 | 236,535 (5%) | 2% | 0 | Common Stock, $0.00001 par value | |
| QXO Inc | Ihsan Essaid | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 127,125 | 720,375 | - | - | Restricted Stock Units | |
| Brown & Brown | J. Hyatt Brown | Director, Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 127,034 | 1,827,556 (0%) | 0% | 0 | Common Stock, $.10 par value | |
| Brown & Brown | J. Powell Brown | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 127,034 | 1,827,556 (0%) | 0% | 0 | Common Stock, $.10 par value | |
| Brown & Brown | P. Barrett Brown | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 127,034 | 1,827,556 (0%) | 0% | 0 | Common Stock, $.10 par value | |
| Arrive AI Inc | Mark Hamm | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 124,969 | 124,969 | - | - | Restricted Stock Award | |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 121,331 | 1,314,664 (7%) | 0% | 0 | Common Stock | |
| Acuren Corp Ltd | Franklin Robert A E | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 120,244 | 1,117,394 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Adam Taylor Sullivan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 31 Dec 2025 | 117,540 | 4,405,704 | - | 15.1 | 1,772,503 | Common Stock |
| Nuvve Holding Corp | Gregory Poilasne | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.37 per share. | 31 Dec 2025 | 117,358 | 150,619 | - | 2.4 | 277,786 | Common Stock |
| Nuvve Holding Corp | Gregory Poilasne | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 117,358 | 0 | - | - | Warrants (right to buy) | |
| Redwire Corp | Peter Cannito | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.60 per share. | 31 Dec 2025 | 116,085 | 674,393 | - | 7.6 | 882,246 | Common Stock, par value $0.0001 per share |
| Oramed Pharma Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 115,000 | 630,256 (3%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 115,000 | 1,429,664 (8%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 115,000 | 1,045,495 (5%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Lawrence Bruno | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.03 per share. | 31 Dec 2025 | 112,681 | 257,438 (0%) | 0% | 16.0 | 1,806,276 | Common Stock |
| Cedar Fair L.P. | Selim Antoine Bassoul | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.34 per share. | 31 Dec 2025 | 110,955 | 537,223 (0%) | 0% | 15.3 | 1,702,050 | Common Stock, par value $0.01 per share |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 1,312,500 | - | - | Restricted Stock Units | |
| CoreWeave Inc (Class A) | Intrator Michael | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 6,003,070 | - | - | Class A Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 1,312,500 | - | - | Restricted Stock Units | |
| CoreWeave Inc (Class A) | McBee Brannin | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 294,561 | - | - | Class A Common Stock | |
| CoreWeave Inc (Class A) | Venturo Brian | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 324,602 | - | - | Class A Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 109,380 | 1,312,500 | - | - | Restricted Stock Units | |
| Flowers Foods Inc | William Jameson McFadden | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 109,303 | 638,781 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 109,000 | 109,000 | - | - | Performance Stock Units | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 108,553 | 1,312,624 | - | - | Class B Common Stock | ||
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 17.67 per share. | 31 Dec 2025 | 108,553 | 0 | - | 17.7 | 1,918,294 | Class A Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 31 Dec 2025 | 108,553 | 108,553 | - | - | Class A Common Stock | ||
| Arrive AI Inc | Todd Pepmeier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 106,464 | 106,464 | - | - | Restricted Stock Award | |
| HighPeak Energy Inc | William Ryan Hightower | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.74 per share. | 31 Dec 2025 | 105,887 | 322,668 | - | 4.7 | 501,904 | Common Stock, par value $0.0001 per share |
| HighPeak Energy Inc | Daniel M. Silver | Director, Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.74 per share. | 31 Dec 2025 | 105,849 | 251,652 | - | 4.7 | 501,724 | Common Stock, par value $0.0001 per share |
| Kforce Inc | Joseph J. Liberatore | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 104,059 | 335,527 (1%) | 0% | 0 | Common Stock | |
| REX American Resources Corp | Edward M. Kress | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 102,482 | 204,964 (3%) | 1% | 0 | Common stock, $.01 par value | |
| Granite Point Mortgage Trust Inc | John Taylor A. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 100,100 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Taylor A. John | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 100,100 | 571,542 (1%) | 0% | - | Common Stock | |
| Innodata Inc | Jack S. Abuhoff | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 100,098 | 1,340,456 (5%) | 0% | 0 | Common Stock | |
| Evercore Inc (Class A) | Timothy LaLonde Gilbert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 0 | - | - | Class K-P Units of Evercore LP | |
| Cogent Comm Holdings Inc | Thaddeus G. Weed | VICE PRESIDENT, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 207,600 (0%) | 0% | 0 | common stock | |
| Cogent Comm Holdings Inc | John B. Chang | VP & CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 188,847 (0%) | 0% | 0 | common stock | |
| Cogent Comm Holdings Inc | Mark Andrew Harris | VP & Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 110,168 (0%) | 0% | 0 | common stock | |
| WillScot Mobile Mini Holdings Corp | Timothy D. Boswell | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 100,000 | - | - | Stock Options (right to buy) | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 100,000 | 490,000 | - | 0.0 | 100 | Common Stock, par value $.001 |
| Sabra Healthcare REIT Inc | Richard K. Matros | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 99,577 | 967,366 (0%) | 0% | 0 | Common Stock | |
| Torrid Holdings Inc | Chinwe Abaelu | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 98,426 | 235,113 | - | 0 | Common Stock | |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 97,328 | 930,495 (5%) | 0% | 0 | Common Stock | |
| Oportun Fin Corp | Patrick Kirscht | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 95,603 | 493,917 (1%) | 0% | - | Common Stock | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 95,221 | 95,221 | - | - | Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 93,693 | 93,693 | - | - | Restricted Stock Units | |
| Alexandria Real Estate Equities Inc | Hunter L. Kass | Co-President and RMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 93,099 | 240,126 (0%) | 0% | 0 | Common Stock | |
| First Guaranty Bancshares Inc | McAnally Bruce | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 31 Dec 2025 | 92,600 | 300,360 (3%) | 0% | 5.4 | 500,040 | COMMON STOCK |
| Zevra Therapeutics Inc | R. LaDuane Clifton | Former CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 86,667 | 0 | - | - | Restricted Stock Unit | |
| Oportun Fin Corp | Kathleen I. Layton | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 86,043 | 245,227 (0%) | 0% | - | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 82,854 | 2,083,102 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 82,854 | 0 (0%) | 0% | 0 | Common Stock | |
| Century Aluminum Co. | Gunnar Gudlaugsson | EVP - Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 82,794 | 226,598 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities Inc | Marc E. Binda | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 81,733 | 185,211 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Gabay Avraham | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 81,216 | 515,256 (2%) | 0% | 0 | Common Stock | |
| WillScot Mobile Mini Holdings Corp | Bradley L. Soultz | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.83 per share. | 31 Dec 2025 | 79,050 | 352,549 (0%) | 0% | 18.8 | 1,488,512 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 72.57 per share. | 31 Dec 2025 | 78,538 | 5,955,509 | - | 72.6 | 5,699,503 | Class A Common Stock |
| Lightwave Logic Inc | James S. Marcelli | Director, CFO, COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.24 per share. | 31 Dec 2025 | 77,758 | 868,293 | - | 3.2 | 251,936 | Common Stock |
| Whitefiber Inc | Thomas Sanfilippo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 76,977 | 59,333 | - | - | Restricted Stock Unit | |
| Whitefiber Inc | Thomas Sanfilippo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 76,977 | 59,333 | - | - | Restricted Stock Unit | |
| Arrive AI Inc | Neerav Shah | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 76,046 | 76,046 | - | - | Restricted Stock Award | |
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 75,949 | 86,076 | - | 30.9 | 2,343,027 | Common Stock |
| Aclaris Therapeutics Inc | James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 73,750 | 177,056 (0%) | 0% | - | Common Stock | |
| Aclaris Therapeutics Inc | James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 73,750 | 0 | - | - | Restricted Stock Units | |
| Aclaris Therapeutics Inc | Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 73,750 | 166,358 (0%) | 0% | - | Common Stock | |
| Aclaris Therapeutics Inc | Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 73,750 | 0 | - | - | Restricted Stock Units | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | 31 Dec 2025 | 71,811 | 71,811 | - | - | Restricted Stock Units | ||
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | 31 Dec 2025 | 71,811 | 71,811 | - | - | Restricted Stock Units | ||
| Lightwave Logic Inc | Thomas E. Zelibor | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.24 per share. | 31 Dec 2025 | 70,732 | 386,722 | - | 3.2 | 229,172 | Common Stock |
| Century Aluminum Co. | Jesse E. Gary | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.18 per share. | 31 Dec 2025 | 67,711 | 534,395 (0%) | 0% | 39.2 | 2,652,917 | Common Stock |
| Conduent Inc | Michael E. Krawitz | EVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 31 Dec 2025 | 65,957 | 1,092,736 (0%) | 0% | 1.9 | 126,637 | Common Stock |
| CoreWeave Inc (Class A) | Venturo Brian | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 72.57 per share. | 31 Dec 2025 | 65,578 | 276,415 | - | 72.6 | 4,758,995 | Class A Common Stock |
| Research Frontiers Inc | Joseph M. Harary | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 65,000 | 355,000 | - | - | Stock Option (right to buy) | |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 63,187 | 136,864 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 63,187 | 126,375 | - | - | Restricted Stock Unit | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 31 Dec 2025 | 62,500 | 3,592,666 | - | 1.5 | 90,625 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 31 Dec 2025 | 62,500 | 3,530,166 | - | 1.5 | 90,625 | Common Stock |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 61,417 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 61,417 | 142,354 (0%) | 0% | 0 | Common Stock | |
| QXO Inc | Sean Smith | SEE REMARKS | 31 Dec 2025 | 61,404 | 121,993 (2%) | 1% | 21.0 | 1,291,940 | Common Stock, $0.00001 par value | |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 10.70 per share. | 31 Dec 2025 | 60,411 | 169,797 | - | 10.7 | 646,398 | Series B Preferred Stock |
| Big Sky Industrial Inc | Joshua L. Batchelor | Director, Ten Percent Owner, Member of 10% owner group | 31 Dec 2025 | 60,151 | 573,224 (40%) | 4% | 2.5 | 149,042 | Common Stock | |
| Acuren Corp Ltd | E. Lillie James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 60,122 | 1,806,291 | - | 0 | Common Stock | |
| Granite Point Mortgage Trust Inc | Morral M. Peter | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 60,060 | 203,287 (0%) | 0% | - | Common Stock | |
| Granite Point Mortgage Trust Inc | Stephen Alpart | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 60,060 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Stephen Alpart | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 60,060 | 278,816 (0%) | 0% | - | Common Stock | |
| Granite Point Mortgage Trust Inc | Peter M. Morral | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 60,060 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Peter M. Morral | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 60,060 | 131,674 (0%) | 0% | - | Common Stock | |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 59,964 | 59,964 | - | - | Restricted Stock Unit | |
| QXO Inc | Ihsan Essaid | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. | 31 Dec 2025 | 58,923 | 177,612 (3%) | 1% | 21.0 | 1,239,740 | Common Stock, $0.00001 par value |
| APi Grp Corp | Franklin Martin E. | Director, Ten Percent Owner | Other type of transaction at price $ 38.97 per share. | 31 Dec 2025 | 57,940 | 8,042,303 | - | 39.0 | 2,257,922 | Common Stock |
| Century Aluminum Co. | Jesse E. Gary | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 57,443 | 591,838 (0%) | 0% | 0 | Common Stock | |
| CoreWeave Inc (Class A) | McBee Brannin | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 72.57 per share. | 31 Dec 2025 | 57,321 | 248,979 | - | 72.6 | 4,159,785 | Class A Common Stock |
| Nabors Ind Ltd | Anthony G. Petrello | Director, CHAIRMAN, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 57,293 | 57,293 | - | - | 2025 Performance Share Units | |
| Core Scientific Inc - Ordinary Shares - New | Todd M. Duchene | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 55,758 | 2,077,880 | - | 0 | Common Stock | |
| Century Aluminum Co. | John DeZee | EVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 54,042 | 186,960 (0%) | 0% | 0 | Common Stock | |
| Interactive Brokers Grp Inc (Class A) | Paul J. Brody | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 53,452 | 2,938,948 (3%) | 0% | 0 | Class A common stock | |
| Granite Point Mortgage Trust Inc | Taylor A. John | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 Dec 2025 | 52,993 | 518,549 (0%) | 0% | 2.4 | 127,713 | Common Stock |
| TKO (Class A) | Nick Khan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 51,225 | 160,292 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Nick Khan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 51,225 | 51,226 | - | - | Restricted Stock Unit | |
| Alexandria Real Estate Equities Inc | John Hart Cole | EVP, Capital Markets & Co-RMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 51,083 | 105,013 (0%) | 0% | 0 | Common Stock | |
| United Fire Grp Inc | Scott Mcintyre | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 50,802 | 0 (0%) | 0% | 0 | UFCS Common Stock | |
| Conduent Inc | Adam Appleby | EVP, Public Sector | 31 Dec 2025 | 50,753 | 374,000 (0%) | 0% | 1.9 | 97,446 | Common Stock | |
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,600 | 672,427 | - | 0 | Common Stock | ||
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,600 | 70,000 | - | 0 | Common Stock | ||
| Cocrystal Pharma Inc | Phillip Frost | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 31 Dec 2025 | 50,000 | 1,838,551 (3%) | 0% | 0.9 | 47,275 | Common Stock |
| Intapp Inc | Coleman Don | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 50,000 | 140,000 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | Don Coleman | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. | 31 Dec 2025 | 50,000 | 497,613 | - | 12 | 600,000 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | 31 Dec 2025 | 50,000 | 25,149,280 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Intrator Michael | Director, CEO and President, Ten Percent Owner | 31 Dec 2025 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,000 | 70,000 | - | 0 | Common Stock | ||
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,000 | 622,427 | - | 0 | Common Stock | ||
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,000 | 70,000 | - | 0 | Common Stock | ||
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, See Remarks | 31 Dec 2025 | 50,000 | 572,427 | - | 0 | Common Stock | ||
| Lightwave Logic Inc | Siraj Nour El-Ahmadi | Director | Sale of securities on an exchange or to another person at price $ 3.15 per share. | 31 Dec 2025 | 49,260 | 99,535 | - | 3.2 | 155,218 | Common Stock |
| Infrared Cameras Holdings Inc | Daniel M. Friedberg | Director, Ten Percent Owner, See Footnotes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 48,900 | 150,107 | - | 0 | Common stock, $0.0001 par value per share | |
| Infrared Cameras Holdings Inc | David Gow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 48,900 | 796,544 | - | 0 | Common Stock | |
| Nabors Ind Ltd | Anthony G. Petrello | Director, CHAIRMAN, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 48,621 | 155,930 (0%) | 0% | 0 | Common Stock | |
| Conduent Inc | Mark Prout | EVP, Chief Information Officer | 31 Dec 2025 | 48,564 | 671,093 (0%) | 0% | 1.9 | 93,243 | Common Stock | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | Former CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. | 31 Dec 2025 | 48,513 | 143,515 (0%) | 0% | 9.0 | 434,676 | Common Stock |
| Vivakor Inc | Albert Johnson | Director | 31 Dec 2025 | 48,082 | 151,947 | - | 0.9 | 41,831 | Common Stock | |
| Kforce Inc | David M. Kelly | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 48,027 | 136,779 (0%) | 0% | 0 | Common Stock | |
| United States Lime & Minerals Inc | Byrne W. Timothy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 119.74 per share. | 31 Dec 2025 | 47,500 | 114,741 (2%) | 0% | 119.7 | 5,687,650 | USLM Common Stock |
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 47,084 | 0 | - | - | Class C Units | |
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 47,084 | 55,763 | - | - | OP Units | |
| First Guaranty Bancshares Inc | Marshall T. Reynolds | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 31 Dec 2025 | 46,297 | 1,993,821 (20%) | 0% | 5.4 | 250,004 | COMMON STOCK |
| Oportun Fin Corp | Joseph Schueller | SVP-Controller, PAO & PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 45,890 | 73,980 (0%) | 0% | - | Common Stock | |
| HighPeak Energy Inc | Michael L. Hollis | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.74 per share. | 31 Dec 2025 | 45,253 | 1,428,312 | - | 4.7 | 214,499 | Common Stock, par value $0.0001 per share |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Dec 2025 | 45,095 | 1,159,313 | - | 10.6 | 479,811 | Common Stock |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Dec 2025 | 45,095 | 229,923 | - | 10.6 | 479,811 | Common Stock |
| Research Frontiers Inc | Darryl Daigle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 45,000 | 361,000 | - | - | Stock Option (right to buy) | |
| Research Frontiers Inc | Alexander Kaganowicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 45,000 | 361,000 | - | - | Stock Option (right to buy) | |
| LendingTree Inc | Scott Peyree | CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 45,000 | 45,000 | - | - | Performance Vested Restricted Stock Units | |
| Guardant Health Inc | Darya Chudova | Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 44,942 | 62,370 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Darya Chudova | Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 44,942 | 9,538 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 44,250 | 325,422 | - | - | Common Stock | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 44,250 | 88,500 | - | - | Restricted Stock Units | |
| Innodata Inc | Ashok Mishra | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 43,179 | 95,179 (0%) | 0% | 0 | Common Stock | |
| Innodata Inc | Rahul Singhal | President & CRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 43,179 | 127,979 (0%) | 0% | 0 | Common Stock | |
| Solid Power Inc (Class A) | John C. Van Scoter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.28 per share. | 31 Dec 2025 | 42,842 | 3,955,175 | - | 4.3 | 183,364 | Common Stock |
| IZEA Worldwide Inc | Patrick J. Venetucci | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. | 31 Dec 2025 | 42,831 | 305,216 (0%) | 0% | 4.4 | 187,600 | Common Stock |
| Fathom Holdings Inc | Marco Fregenal | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Dec 2025 | 42,079 | 1,557,019 | - | 1.0 | 42,500 | Common Stock |
| Century Aluminum Co. | Gunnar Gudlaugsson | EVP - Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.18 per share. | 31 Dec 2025 | 41,886 | 184,712 (0%) | 0% | 39.2 | 1,641,093 | Common Stock |
| Big Sky Industrial Inc | Joshua L. Batchelor | Director, Ten Percent Owner, Member of 10% owner group | 31 Dec 2025 | 41,229 | 392,901 (28%) | 2% | 2.5 | 102,157 | Common Stock | |
| Redwire Corp | Chris Edmunds | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 40,500 | 147,941 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kingstone Cos. Inc | Meryl S. Golden | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 40,000 | 261,675 (2%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 39,831 | 395,110 (0%) | 0% | 0 | Common Stock | |
| Laureate Education Inc | Eilif Serck-Hanssen | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.94 per share. | 31 Dec 2025 | 38,699 | 1,111,366 | - | 33.9 | 1,313,444 | Common Stock |
| Artesian Resources Corp (Class A) | Dian C. Taylor | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 38,450 | 0 (0%) | 0% | 0 | Class A Non-voting Common Stock | |
| TKO (Class A) | Andrew M. Schleimer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 38,377 | 38,377 | - | - | Restricted Stock Unit | |
| TKO (Class A) | Nick Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 38,377 | 38,377 | - | - | Restricted Stock Unit | |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Grant, award, or other acquisition of securities at price $ 37.38 per share. | 31 Dec 2025 | 38,237 | 191,705 (0%) | 0% | 37.4 | 1,429,299 | Common Stock |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Sale or transfer of securities back to the company at price $ 88.55 per share. | 31 Dec 2025 | 38,237 | 153,468 (0%) | 0% | 88.5 | 3,385,886 | Common Stock |
| Kforce Inc | Jeffrey B. Hackman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 37,622 | 116,799 (0%) | 0% | 0 | Common Stock | |
| InvenTrust Properties Corp | Daniel J. Busch | Director, President & C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 37,221 | 179,509 | - | - | Common Stock | |
| Fold Holdings Inc (Class A) | Jonathan Kirkwood | Director, Ten Percent Owner | 31 Dec 2025 | 37,024 | 37,024 | - | - | Warrant to purchase shares of Common Stock | ||
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Other type of transaction at price $ 30.85 per share. | 31 Dec 2025 | 36,983 | 48,150 | - | 30.9 | 1,140,926 | Common Stock |
| Century Aluminum Co. | Matt Aboud | SVP, Strategy & Business Devt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 36,550 | 99,139 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Dec 2025 | 35,450 | 486,863 (0%) | 0% | 0 | Common Stock | |
| Peoples Bancorp Inc (Marietta, OH) | Brooke Williams James | Director | 31 Dec 2025 | 34,687 | 265,758 (1%) | 0% | 30.2 | 1,048,068 | Common Stock | |
| ImmunityBio Inc | Richard Adcock | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 34,483 | 368,901 | - | 0 | Common Stock | |
| ImmunityBio Inc | Richard Adcock | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 34,483 | 51,731 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Rebecca Fine A. | EVP, Global CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 34,092 | 0 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Fine A. Rebecca | EVP, Global CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 34,092 | 124,361 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | Former CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 34,000 | 0 | - | - | Restricted Stock Unit | |
| Aclaris Therapeutics Inc | James Loerop | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. | 31 Dec 2025 | 33,994 | 143,062 (0%) | 0% | 3.0 | 102,322 | Common Stock |
| Monarch Casino & Resort Inc | Bob Farahi | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 33,333 | 166,667 | - | - | Options / Right to Buy | |
| Progyny Inc | Michael Sturmer | PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.84 per share. | 31 Dec 2025 | 33,028 | 255,205 (0%) | 0% | 25.8 | 853,444 | Common Stock |
| Granite Point Mortgage Trust Inc | Karber Michael J. | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 32,532 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Karber J. Michael | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 32,532 | 100,303 (0%) | 0% | - | Common Stock | |
| Commercial Vehicle Grp Inc | James R. Ray | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. | 31 Dec 2025 | 32,455 | 1,038,515 (3%) | 0% | 1.4 | 46,735 | Common Stock, $0.01 par value |
| Core Laboratories N.V. | Christopher S. Hill | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.03 per share. | 31 Dec 2025 | 32,152 | 110,202 (0%) | 0% | 16.0 | 515,397 | Common Stock |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 204.08 per share. | 31 Dec 2025 | 32,022 | 104,842 | - | 204.1 | 6,535,050 | Class A Common Stock |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 31,650 | 90,733 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Robert O. Stephenson | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 31,426 | 147,000 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Robert O. Stephenson | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 31,426 | 31,426 (0%) | 0% | 0 | Common Stock | |
| Axsome Therapeutics Inc | Saad E. Mark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.95 per share. | 31 Dec 2025 | 31,346 | 41,348 (0%) | 0% | 5.0 | 155,163 | Common Stock |
| Axsome Therapeutics Inc | E. Mark Saad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 31,346 | 0 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | E. Saad Mark | Director | Sale of securities on an exchange or to another person at price $ 165.18 per share. | 31 Dec 2025 | 31,346 | 10,002 (0%) | 0% | 165.2 | 5,177,732 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,977 | 402,708 | - | - | Restricted Stock Units | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,977 | 6,034,047 | - | - | Class A Common Stock | |
| Century Aluminum Co. | Agust F. Hafberg | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,878 | 86,138 (0%) | 0% | 0 | Common Stock | |
| Granite Point Mortgage Trust Inc | Morral M. Peter | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 Dec 2025 | 30,660 | 172,627 (0%) | 0% | 2.4 | 73,891 | Common Stock |
| Granite Point Mortgage Trust Inc | Stephen Alpart | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 Dec 2025 | 30,660 | 248,156 (0%) | 0% | 2.4 | 73,891 | Common Stock |
| Granite Point Mortgage Trust Inc | Peter M. Morral | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 Dec 2025 | 30,660 | 101,014 (0%) | 0% | 2.4 | 73,891 | Common Stock |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,643 | 91,927 | - | - | Restricted Stock Units | |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,643 | 494,471 (0%) | 0% | 0 | Common Stock | |
| PTC | Kristian P. Talvitie | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,619 | 43,005 (0%) | 0% | 0 | Common Stock | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.55 per share. | 31 Dec 2025 | 30,459 | 1,809,827 (5%) | 0% | 6.5 | 199,375 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.55 per share. | 31 Dec 2025 | 30,459 | 1,809,827 (5%) | 0% | 6.5 | 199,375 | Common Stock |
| ImmunityBio Inc | David C. Sachs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,397 | 45,602 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | David C. Sachs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,397 | 256,017 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 31 Dec 2025 | 30,000 | 693,077 | - | 2.1 | 62,400 | Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 275,559 | - | - | Stock Option (Right to Buy) | |
| Oramed Pharma Inc | Daniel Aghion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 107,191 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 163,109 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 119,720 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 98,930 (0%) | 0% | - | Common Stock | |
| Fold Holdings Inc (Class A) | Jonathan Kirkwood | Director, Ten Percent Owner | 31 Dec 2025 | 30,000 | 30,000 | - | - | Common Stock | ||
| Broadcom | Kirsten M. Spears | CFO & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 347.82 per share. | 31 Dec 2025 | 29,977 | 277,237 (0%) | 0% | 347.8 | 10,426,630 | Common Stock, $0.001 par value |
| Alexandria Real Estate Equities Inc | Lawrence J. Diamond | Co-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 28,965 | 160,435 (0%) | 0% | 0 | Common Stock | |
| Wheeler Real Estate Investment Trust Inc | Joseph D. Stilwell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 28,885 | 108,954 | - | - | Series D Cumulative Convertible Preferred Stock | |
| Regeneron Pharma | Leonard S. Schleifer | Director, Bd. Co-Chair, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 28,570 | 243,093 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Leonard S. Schleifer | Director, Bd. Co-Chair, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 28,570 | 595,077 | - | - | 2020 Performance Stock Units | |
| Regeneron Pharma | Leonard S. Schleifer | Director, Bd. Co-Chair, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 772.09 per share. | 31 Dec 2025 | 28,570 | 214,523 (0%) | 0% | 772.1 | 22,058,611 | Common Stock |
| Regeneron Pharma | George D. Yancopoulos | Director, Bd. Co-Chair, President & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 772.09 per share. | 31 Dec 2025 | 28,570 | 310,460 (0%) | 0% | 772.1 | 22,058,611 | Common Stock |
| Regeneron Pharma | George D. Yancopoulos | Director, Bd. Co-Chair, President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 28,570 | 339,030 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | George D. Yancopoulos | Director, Bd. Co-Chair, President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 28,570 | 595,077 | - | - | 2020 Performance Stock Units | |
| Realty Income - REIT | Sumit Roy | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.37 per share. | 31 Dec 2025 | 28,270 | 364,310 (0%) | 0% | 56.4 | 1,593,580 | Common Stock |
| Hyperion DeFi Inc | David Knox | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.59 per share. | 31 Dec 2025 | 27,950 | 327,950 (1%) | 0% | 3.6 | 100,341 | Common Stock, par value $0.0001 |
| TKO (Class A) | Nick Khan | Director | Sale of securities on an exchange or to another person at price $ 204.08 per share. | 31 Dec 2025 | 27,907 | 122,867 | - | 204.1 | 5,695,261 | Class A Common Stock |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 27,842 | 111,366 | - | - | Restricted Stock Units | |
| Healthcare Services Grp Inc | Theodore Wahl | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 27,842 | 522,313 (0%) | 0% | 0 | Common Stock | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.60 per share. | 31 Dec 2025 | 27,153 | 1,836,980 (5%) | 0% | 6.6 | 179,327 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.60 per share. | 31 Dec 2025 | 27,153 | 1,836,980 (5%) | 0% | 6.6 | 179,327 | Common Stock |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 26,711 | 119,656 | - | - | Restricted Stock Units | |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 26,711 | 1,702,226 (4%) | 0% | 0 | Common Stock | |
| Solid Power Inc (Class A) | Linda C. Heller | CFO, Treasurer, & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.28 per share. | 31 Dec 2025 | 26,605 | 1,803,587 | - | 4.3 | 113,869 | Common Stock |
| Alight Inc (Class A) | Russell P. Fradin | Director | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 31 Dec 2025 | 25,641 | 200,969 | - | 2.0 | 50,000 | Class A Common Stock |
| Core & Main Inc (Class A) | Whittenburg Mark G. | General Counsel and Secretary | 31 Dec 2025 | 25,500 | 227,312 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 72.02 per share. | 31 Dec 2025 | 25,260 | 12,886 | - | 72.0 | 1,819,208 | Class A Common Stock |
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 24,952 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 24,952 | 52,527 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 24,952 | 41,670 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 24,952 | 0 | - | - | Performance Shares | |
| DuPont de Nemours | Edward D. Breen | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.40 per share. | 31 Dec 2025 | 24,574 | 301,048 (0%) | 0% | 40.4 | 992,839 | Common Stock |
| Infrared Cameras Holdings Inc | Petros Kitsos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 24,450 | 89,088 | - | 0 | Common Stock | |
| Infrared Cameras Holdings Inc | Margaret M. Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 24,450 | 89,088 | - | 0 | Common Stock | |
| Infrared Cameras Holdings Inc | Stuart V Flavin III | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 24,450 | 102,453 | - | 0 | Common Stock | |
| Navient Corp | Yowan L David | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.00 per share. | 31 Dec 2025 | 24,075 | 546,402 (0%) | 0% | 13 | 312,975 | Common Stock |
| Whitefiber Inc | Thomas Sanfilippo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.85 per share. | 31 Dec 2025 | 24,033 | 17,644 | - | 29.8 | 717,385 | Ordinary Shares, $.01 par value |
| Whitefiber Inc | Thomas Sanfilippo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.85 per share. | 31 Dec 2025 | 24,033 | 17,644 | - | 29.8 | 717,385 | Ordinary Shares, $.01 par value |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 2,073,514 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 95,989 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 2,024,245 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 95,989 | - | - | Restricted Stock Units | |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 77.95 per share. | 31 Dec 2025 | 23,986 | 669,091 | - | 78.0 | 1,869,728 | Common Stock |
| TKO (Class A) | Seth D. Krauss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 23,986 | 23,986 | - | - | Restricted Stock Units | |
| PHINIA Inc | Brady D. Ericson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.69 per share. | 31 Dec 2025 | 23,732 | 381,019 | - | 62.7 | 1,487,759 | Common Stock |
| Gaming and Leisure Properties Inc | Steven L. Ladany | SVP Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 23,730 | 86,199 (0%) | 0% | 0 | Common Stock | |
| Interactive Brokers Grp Inc (Class A) | Earl H. Nemser | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 23,240 | 451,052 (0%) | 0% | 0 | Class A common stock | |
| NewtekOne Inc | Barry Sloane | Director, President, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.11 per share. | 31 Dec 2025 | 23,229 | 1,190,585 (5%) | 0% | 12.1 | 281,303 | Common Stock |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 166,790 | - | 0 | Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 1,204,408 | - | 0 | Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 276,981 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 276,981 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 1,096,180 | - | 0 | Common Stock | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 276,981 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 276,981 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 22,918 | 275,018 | - | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.